| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
42,366 |
41,097 |
$9.23M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
28,946 |
28,084 |
$7.10M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,474 |
1,427 |
$3.78M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,129 |
4,016 |
$3.40M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
4,351 |
4,254 |
$3.15M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,774 |
1,737 |
$2.65M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
1,190 |
1,147 |
$2.61M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,519 |
2,243 |
$2.45M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,702 |
3,348 |
$2.24M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
12,998 |
5,478 |
$1.98M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,375 |
1,369 |
$1.95M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,644 |
10,103 |
$1.86M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,315 |
12,961 |
$1.74M |
| 95782 |
|
960 |
951 |
$1.63M |
| G0378 |
Hospital observation service, per hour |
6,448 |
6,073 |
$1.54M |
| 76770 |
|
4,319 |
4,248 |
$1.43M |
| 92587 |
|
6,186 |
6,053 |
$1.42M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
4,183 |
3,982 |
$1.24M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
9,672 |
3,832 |
$1.22M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
4,530 |
4,371 |
$1.17M |
| 93325 |
|
4,949 |
4,801 |
$1.12M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,191 |
6,728 |
$984K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
9,385 |
5,660 |
$968K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,398 |
2,823 |
$896K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,397 |
2,305 |
$886K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,965 |
2,326 |
$877K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
19,735 |
19,189 |
$771K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
253 |
247 |
$768K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,535 |
7,421 |
$754K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,112 |
2,960 |
$748K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,300 |
1,240 |
$740K |
| A0425 |
Ground mileage, per statute mile |
6,748 |
5,978 |
$726K |
| J3490 |
Unclassified drugs |
88,812 |
45,115 |
$685K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
4,622 |
4,574 |
$659K |
| 71046 |
Radiologic examination, chest; 2 views |
7,911 |
7,549 |
$634K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,111 |
1,976 |
$608K |
| 01922 |
|
2,686 |
2,601 |
$595K |
| J2357 |
Injection, omalizumab, 5 mg |
229 |
111 |
$553K |
| V2020 |
Frames, purchases |
15,310 |
14,808 |
$549K |
| 83655 |
|
22,173 |
21,967 |
$501K |
| 96415 |
|
990 |
852 |
$461K |
| 94375 |
|
3,779 |
3,638 |
$452K |
| 95819 |
|
1,077 |
1,060 |
$426K |
| 87631 |
|
2,538 |
2,500 |
$415K |
| 92567 |
|
7,308 |
7,139 |
$414K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,154 |
1,728 |
$409K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,394 |
2,300 |
$385K |
| A0434 |
Specialty care transport (sct) |
990 |
959 |
$372K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
749 |
719 |
$350K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
535 |
371 |
$328K |
| 97165 |
|
2,210 |
2,123 |
$323K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,203 |
6,812 |
$315K |
| 80053 |
Comprehensive metabolic panel |
25,868 |
22,783 |
$307K |
| 74018 |
|
3,807 |
3,543 |
$303K |
| 12011 |
|
825 |
814 |
$295K |
| 87507 |
|
1,066 |
1,051 |
$290K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,300 |
11,706 |
$279K |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
8,496 |
8,294 |
$277K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
822 |
804 |
$268K |
| 94060 |
|
1,738 |
1,712 |
$266K |
| 97161 |
|
2,534 |
2,460 |
$262K |
| 73590 |
|
3,252 |
2,782 |
$250K |
| 93320 |
|
4,187 |
4,077 |
$242K |
| 84439 |
|
12,802 |
12,427 |
$238K |
| J3535 |
Drug administered through a metered dose inhaler |
4,436 |
3,917 |
$232K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
3,029 |
2,999 |
$223K |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
11,334 |
10,910 |
$221K |
| 92015 |
Determination of refractive state |
14,520 |
13,841 |
$219K |
| 95816 |
|
556 |
546 |
$212K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,086 |
11,823 |
$209K |
| 73090 |
|
2,548 |
2,028 |
$203K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,885 |
22,040 |
$198K |
| 73552 |
|
2,302 |
1,978 |
$196K |
| 93975 |
|
690 |
676 |
$193K |
| 74019 |
|
3,322 |
3,184 |
$192K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,729 |
6,237 |
$190K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
11,372 |
10,898 |
$186K |
| V2100 |
Sphere, single vision, plano to plus or minus 4.00, per lens |
4,971 |
4,899 |
$181K |
| 74230 |
|
860 |
797 |
$181K |
| 73100 |
|
1,898 |
1,494 |
$178K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
10,166 |
9,464 |
$176K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,338 |
4,155 |
$169K |
| 73610 |
|
1,788 |
1,595 |
$158K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,271 |
1,212 |
$156K |
| 76536 |
|
573 |
563 |
$154K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,022 |
994 |
$145K |
| 72082 |
|
1,545 |
1,482 |
$141K |
| 73521 |
|
1,387 |
1,329 |
$140K |
| 73630 |
|
1,670 |
1,466 |
$139K |
| 92611 |
|
777 |
733 |
$136K |
| 73070 |
|
1,465 |
1,159 |
$135K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
259 |
258 |
$130K |
| 77080 |
|
802 |
756 |
$128K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,202 |
1,148 |
$124K |
| 93225 |
|
985 |
949 |
$121K |
| 77072 |
|
1,248 |
1,232 |
$120K |
| 36415 |
Collection of venous blood by venipuncture |
34,108 |
30,610 |
$118K |
| 93226 |
|
1,064 |
1,024 |
$117K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,827 |
4,751 |
$116K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
266 |
253 |
$116K |
| 12001 |
|
291 |
284 |
$113K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
2,424 |
2,292 |
$111K |
| 72081 |
|
1,319 |
1,270 |
$110K |
| 92002 |
|
2,930 |
2,815 |
$109K |
| 80050 |
General health panel |
4,329 |
4,218 |
$107K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
26,070 |
15,089 |
$107K |
| J2704 |
Injection, propofol, 10 mg |
9,384 |
8,650 |
$106K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,682 |
1,671 |
$106K |
| 92579 |
|
2,156 |
2,131 |
$104K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
960 |
864 |
$101K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,106 |
10,552 |
$99K |
| 92610 |
|
816 |
793 |
$98K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,945 |
1,813 |
$98K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,508 |
11,306 |
$97K |
| 97162 |
|
824 |
790 |
$97K |
| 36430 |
|
465 |
354 |
$90K |
| 31622 |
|
43 |
36 |
$89K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
300 |
294 |
$88K |
| 73080 |
|
994 |
868 |
$87K |
| 80061 |
Lipid panel |
6,564 |
6,414 |
$85K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,681 |
5,561 |
$83K |
| 73140 |
|
1,167 |
1,001 |
$82K |
| V2104 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens |
2,546 |
2,450 |
$80K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,082 |
3,392 |
$79K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,405 |
7,914 |
$79K |
| 92526 |
|
710 |
470 |
$79K |
| 51701 |
|
2,935 |
2,867 |
$78K |
| 86140 |
|
9,515 |
8,647 |
$75K |
| 82728 |
|
4,722 |
4,338 |
$73K |
| 83516 |
|
4,525 |
3,997 |
$72K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,393 |
1,341 |
$71K |
| 0099U |
|
370 |
338 |
$69K |
| 92555 |
|
951 |
932 |
$68K |
| 72170 |
|
906 |
834 |
$68K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,110 |
3,051 |
$67K |
| 92523 |
|
690 |
675 |
$66K |
| 82784 |
|
4,587 |
4,376 |
$66K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,512 |
3,136 |
$61K |
| 74240 |
|
294 |
285 |
$61K |
| 76870 |
|
361 |
345 |
$60K |
| 73562 |
|
747 |
695 |
$59K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
168 |
140 |
$59K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,213 |
1,160 |
$59K |
| 94760 |
|
4,004 |
3,869 |
$59K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,173 |
1,084 |
$58K |
| 95812 |
|
73 |
72 |
$58K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,488 |
2,452 |
$57K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,593 |
3,300 |
$56K |
| 76885 |
|
194 |
190 |
$56K |
| 92552 |
|
364 |
357 |
$55K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,058 |
5,221 |
$54K |
| 90378 |
|
236 |
118 |
$53K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,001 |
4,445 |
$49K |
| 76376 |
|
198 |
192 |
$48K |
| 94761 |
|
3,351 |
3,156 |
$48K |
| 86003 |
|
2,045 |
1,870 |
$47K |
| 96409 |
|
697 |
390 |
$46K |
| 83970 |
|
850 |
796 |
$46K |
| 73130 |
|
627 |
552 |
$46K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
364 |
322 |
$46K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
13 |
13 |
$45K |
| 87581 |
|
1,057 |
1,013 |
$44K |
| 87486 |
|
1,056 |
1,013 |
$44K |
| 0097U |
|
215 |
194 |
$43K |
| 81001 |
|
14,297 |
13,412 |
$43K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,632 |
4,146 |
$43K |
| 85007 |
|
6,432 |
5,168 |
$41K |
| 80069 |
|
2,608 |
2,281 |
$40K |
| 82247 |
|
5,059 |
2,911 |
$40K |
| 84305 |
|
1,515 |
1,491 |
$39K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,726 |
4,398 |
$39K |
| 87077 |
|
3,775 |
3,549 |
$39K |
| 85027 |
|
6,446 |
5,173 |
$34K |
| 83550 |
|
3,372 |
3,221 |
$34K |
| A0200 |
Non-emergency transportation: ancillary: lodging escort |
1,382 |
364 |
$34K |
| 96367 |
|
153 |
133 |
$33K |
| 85652 |
|
6,126 |
5,609 |
$33K |
| 82803 |
|
2,576 |
2,077 |
$32K |
| 70360 |
|
392 |
384 |
$32K |
| 82570 |
|
4,691 |
4,056 |
$31K |
| 87081 |
|
3,378 |
3,331 |
$31K |
| 73560 |
|
422 |
329 |
$31K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
895 |
329 |
$31K |
| 87070 |
|
2,959 |
2,763 |
$30K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
73 |
63 |
$30K |
| 96450 |
|
29 |
24 |
$28K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
32 |
24 |
$28K |
| 87186 |
|
3,680 |
3,475 |
$28K |
| 86900 |
|
1,666 |
1,373 |
$27K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,180 |
2,431 |
$27K |
| 74181 |
|
40 |
40 |
$25K |
| 83540 |
|
3,513 |
3,341 |
$24K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,596 |
1,262 |
$24K |
| 73000 |
|
301 |
276 |
$23K |
| 51600 |
|
48 |
48 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
643 |
592 |
$22K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,095 |
864 |
$22K |
| 88342 |
|
323 |
314 |
$22K |
| 90686 |
|
701 |
679 |
$22K |
| 96376 |
|
1,483 |
979 |
$21K |
| 42830 |
|
25 |
25 |
$21K |
| 36591 |
|
518 |
381 |
$21K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
163 |
163 |
$21K |
| 83735 |
|
3,936 |
3,182 |
$21K |
| 83880 |
|
783 |
687 |
$21K |
| 36416 |
|
7,212 |
6,301 |
$21K |
| A0210 |
Non-emergency transportation: ancillary: meals-escort |
2,222 |
404 |
$21K |
| J9370 |
Vincristine sulfate, 1 mg |
306 |
224 |
$20K |
| 36000 |
|
295 |
274 |
$19K |
| 87088 |
|
1,951 |
1,876 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,850 |
1,613 |
$19K |
| 88108 |
|
309 |
263 |
$18K |
| 84100 |
|
4,522 |
3,748 |
$18K |
| 86923 |
|
728 |
610 |
$18K |
| 86850 |
|
1,644 |
1,354 |
$18K |
| 82248 |
|
3,381 |
1,926 |
$18K |
| 92582 |
|
589 |
577 |
$18K |
| 76377 |
|
841 |
732 |
$17K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
1,054 |
822 |
$17K |
| 94664 |
|
614 |
604 |
$17K |
| 82533 |
|
838 |
670 |
$17K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
111 |
109 |
$17K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,894 |
2,715 |
$16K |
| V2756 |
Eye glass case |
13,975 |
13,617 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
315 |
312 |
$16K |
| 85610 |
|
3,128 |
2,416 |
$16K |
| 82397 |
|
934 |
903 |
$16K |
| 82977 |
|
2,124 |
1,988 |
$16K |
| 86376 |
|
985 |
952 |
$15K |
| 94150 |
|
127 |
124 |
$15K |
| 85046 |
|
2,704 |
2,372 |
$14K |
| 97803 |
|
795 |
788 |
$14K |
| 74455 |
|
61 |
60 |
$14K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
435 |
420 |
$14K |
| 77075 |
|
56 |
53 |
$14K |
| 84703 |
|
3,453 |
3,264 |
$14K |
| B4088 |
Gastrostomy/jejunostomy tube, low-profile, any material, any type, each |
164 |
146 |
$14K |
| 84403 |
|
735 |
707 |
$14K |
| 70210 |
|
120 |
118 |
$13K |
| 87430 |
|
770 |
754 |
$13K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
483 |
449 |
$13K |
| 82330 |
|
1,208 |
1,088 |
$13K |
| 97802 |
|
442 |
439 |
$12K |
| 87147 |
|
1,958 |
1,881 |
$12K |
| 80076 |
|
1,016 |
967 |
$12K |
| 70543 |
|
16 |
16 |
$12K |
| 87040 |
|
1,766 |
1,457 |
$12K |
| 36592 |
|
704 |
654 |
$12K |
| 92651 |
|
54 |
53 |
$12K |
| 87205 |
|
2,203 |
1,932 |
$11K |
| 93976 |
|
32 |
32 |
$11K |
| 83002 |
|
699 |
658 |
$11K |
| 84156 |
|
2,604 |
2,368 |
$11K |
| 94621 |
|
27 |
27 |
$11K |
| 83690 |
|
2,199 |
2,108 |
$10K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
7,195 |
4,387 |
$10K |
| A4217 |
Sterile water/saline, 500 ml |
1,219 |
787 |
$10K |
| 97166 |
|
69 |
68 |
$10K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,098 |
949 |
$10K |
| 83001 |
|
620 |
579 |
$10K |
| 86800 |
|
718 |
697 |
$10K |
| 82947 |
|
1,386 |
1,182 |
$9K |
| 82785 |
|
630 |
563 |
$9K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
552 |
441 |
$9K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$9K |
| 82610 |
|
539 |
516 |
$8K |
| 86902 |
|
584 |
333 |
$8K |
| 00635 |
|
28 |
26 |
$8K |
| 85651 |
|
1,860 |
1,778 |
$8K |
| 73110 |
|
78 |
74 |
$8K |
| 82043 |
|
1,300 |
1,257 |
$8K |
| 31526 |
|
12 |
12 |
$8K |
| 83605 |
|
1,497 |
1,305 |
$7K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
1,806 |
1,707 |
$7K |
| 83021 |
|
339 |
284 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
51 |
50 |
$7K |
| 88304 |
|
211 |
205 |
$7K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
318 |
307 |
$7K |
| 80164 |
|
422 |
398 |
$6K |
| 82550 |
|
980 |
885 |
$6K |
| 86769 |
|
97 |
90 |
$6K |
| 80306 |
|
962 |
926 |
$6K |
| 80177 |
|
384 |
374 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
275 |
242 |
$5K |
| 92586 |
|
13 |
13 |
$5K |
| 83993 |
|
294 |
286 |
$5K |
| 82150 |
|
884 |
850 |
$5K |
| 86592 |
|
293 |
280 |
$5K |
| 82310 |
|
912 |
809 |
$5K |
| 96401 |
|
610 |
405 |
$5K |
| 86901 |
|
1,582 |
1,313 |
$5K |
| 82670 |
|
185 |
171 |
$4K |
| 43760 |
|
14 |
14 |
$4K |
| 43762 |
|
12 |
12 |
$4K |
| 82657 |
|
116 |
111 |
$4K |
| 85730 |
|
1,314 |
1,185 |
$4K |
| 86355 |
|
99 |
89 |
$4K |
| 94645 |
|
44 |
37 |
$4K |
| 85014 |
|
1,765 |
1,464 |
$4K |
| 84270 |
|
254 |
246 |
$4K |
| 84402 |
|
260 |
252 |
$4K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
737 |
707 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
931 |
729 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
294 |
281 |
$4K |
| 82340 |
|
531 |
507 |
$4K |
| 83520 |
|
266 |
224 |
$4K |
| 86160 |
|
453 |
387 |
$4K |
| 94728 |
|
38 |
38 |
$4K |
| 90717 |
|
28 |
28 |
$4K |
| 93270 |
|
25 |
25 |
$3K |
| 73030 |
|
46 |
39 |
$3K |
| 87400 |
|
207 |
203 |
$3K |
| 89051 |
|
602 |
529 |
$3K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
25 |
24 |
$3K |
| 90691 |
|
63 |
61 |
$3K |
| 74430 |
|
16 |
14 |
$3K |
| 86038 |
|
195 |
182 |
$3K |
| 83020 |
|
156 |
152 |
$3K |
| 87529 |
|
70 |
38 |
$3K |
| 84295 |
|
511 |
458 |
$3K |
| 95700 |
|
14 |
13 |
$3K |
| 88300 |
|
146 |
140 |
$2K |
| 83615 |
|
622 |
536 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
301 |
287 |
$2K |
| 94644 |
|
186 |
169 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
889 |
770 |
$2K |
| 81025 |
|
877 |
842 |
$2K |
| 82607 |
|
107 |
103 |
$2K |
| 83498 |
|
101 |
97 |
$2K |
| 87328 |
|
137 |
136 |
$2K |
| 86359 |
|
86 |
77 |
$2K |
| 85240 |
|
78 |
65 |
$2K |
| 84132 |
|
413 |
385 |
$2K |
| 76010 |
|
70 |
68 |
$2K |
| 86317 |
|
69 |
52 |
$2K |
| 90734 |
|
14 |
14 |
$2K |
| 86665 |
|
180 |
110 |
$2K |
| 82962 |
|
1,841 |
1,020 |
$2K |
| 86357 |
|
70 |
64 |
$2K |
| 93786 |
|
14 |
14 |
$2K |
| 84145 |
|
715 |
673 |
$2K |
| 73620 |
|
16 |
12 |
$2K |
| 72100 |
|
26 |
26 |
$1K |
| 84484 |
|
360 |
311 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25 |
25 |
$1K |
| 85018 |
|
1,180 |
940 |
$1K |
| 87329 |
|
89 |
88 |
$1K |
| 86480 |
|
29 |
25 |
$1K |
| 87641 |
|
30 |
29 |
$1K |
| 29105 |
|
13 |
12 |
$1K |
| 86255 |
|
41 |
36 |
$1K |
| 81003 |
|
486 |
472 |
$1K |
| 88302 |
|
15 |
15 |
$1K |
| 84146 |
|
67 |
67 |
$1K |
| 86360 |
|
43 |
38 |
$1K |
| 80074 |
|
66 |
62 |
$1K |
| 80183 |
|
68 |
66 |
$1K |
| 86664 |
|
117 |
109 |
$1K |
| 87420 |
|
109 |
105 |
$1K |
| 86663 |
|
92 |
84 |
$964.53 |
| 87427 |
|
59 |
58 |
$905.30 |
| 87045 |
|
71 |
70 |
$855.06 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
142 |
128 |
$848.65 |
| 97116 |
|
17 |
12 |
$845.65 |
| 84550 |
|
245 |
227 |
$834.04 |
| 93788 |
|
14 |
14 |
$828.94 |
| 85378 |
|
429 |
357 |
$806.80 |
| 82024 |
|
14 |
14 |
$781.55 |
| 82652 |
|
30 |
27 |
$776.05 |
| L8613 |
Ossicula implant |
77 |
72 |
$723.72 |
| 82664 |
|
13 |
12 |
$695.54 |
| 87449 |
|
54 |
49 |
$641.22 |
| 80047 |
|
704 |
631 |
$622.53 |
| 82438 |
|
124 |
110 |
$607.92 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
101 |
97 |
$577.43 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
513 |
487 |
$577.25 |
| 87046 |
|
46 |
45 |
$559.10 |
| J7070 |
Infusion, d5w, 1000 cc |
114 |
83 |
$503.53 |
| 73060 |
|
12 |
12 |
$479.19 |
| 86703 |
|
37 |
36 |
$341.41 |
| V2107 |
Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens |
13 |
13 |
$339.04 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
713 |
571 |
$333.89 |
| 80197 |
|
22 |
12 |
$317.99 |
| 86356 |
|
15 |
12 |
$316.31 |
| 84480 |
|
25 |
24 |
$306.64 |
| 86318 |
|
52 |
52 |
$276.21 |
| 80184 |
|
16 |
12 |
$235.64 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
15 |
12 |
$217.50 |
| 82390 |
|
14 |
12 |
$210.73 |
| 83525 |
|
15 |
15 |
$205.17 |
| 80175 |
|
13 |
13 |
$198.59 |
| 82085 |
|
15 |
12 |
$194.04 |
| 80349 |
|
55 |
53 |
$173.74 |
| 82565 |
|
74 |
69 |
$150.32 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
126 |
79 |
$147.50 |
| 82010 |
|
36 |
27 |
$123.96 |
| 86225 |
|
23 |
13 |
$122.34 |
| 70310 |
|
154 |
153 |
$108.12 |
| 80143 |
|
179 |
160 |
$106.96 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
1,457 |
1,300 |
$105.13 |
| 85660 |
|
13 |
12 |
$87.68 |
| 85347 |
|
20 |
12 |
$43.73 |
| 80179 |
|
122 |
105 |
$40.34 |
| 82435 |
|
29 |
27 |
$8.94 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
526 |
465 |
$0.00 |
| 82077 |
|
97 |
95 |
$0.00 |
| 2023F |
|
688 |
686 |
$0.00 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
22 |
12 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
340 |
324 |
$0.00 |
| J7699 |
Noc drugs, inhalation solution administered through dme |
69 |
64 |
$0.00 |
| J2545 |
Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg |
12 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
77 |
50 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
65 |
24 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
72 |
70 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
15 |
15 |
$0.00 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
17 |
12 |
$0.00 |
| 94799 |
|
18 |
18 |
$0.00 |